Treatment Patterns in Metastatic Prostate Cancer

Status Completed

Clinical Trial Summary

This study will evaluate treatment patterns, mortality, healthcare resource utilization, and costs in patients with prostate cancer with bone metastases (primary objectives). Additionally, this study will evaluate opioid/analgesic use among lines of therapy in this patient population (secondary objective). The study is descriptive in nature and is meant to provide a greater understanding of the patterns of therapy observed in real-world clinical practice (in the absence of clear guideline recommendations with regards to treatment sequencing), to contribute to a greater understanding of the major cost drivers (thus better-informing payers), and to examine real-world mortality in such patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02729103
Study type	Observational
Source	Bayer
Contact
Status	Completed
Phase	N/A
Start date	October 31, 2016
Completion date	January 19, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03982095` - Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer
Recruiting	`NCT05667636` - Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP	Phase 2
Terminated	`NCT01996696` - Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate	Phase 2
Completed	`NCT01431391` - Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer	Phase 2
Completed	`NCT03289130` - Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness
Recruiting	`NCT04462926` - Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed	N/A
Completed	`NCT00001446` - A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer	Phase 2
Completed	`NCT00956228` - Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer	Phase 1/Phase 2
Completed	`NCT00247312` - Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial	Phase 3
Completed	`NCT00126854` - High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation	N/A
Completed	`NCT00174863` - Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer	Phase 2
Terminated	`NCT04221828` - Trial of NanoPac Focal Therapy for Prostate Cancer	Phase 2
Completed	`NCT00001266` - A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma	Phase 2
Active, not recruiting	`NCT03935282` - Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors	N/A
Completed	`NCT03693742` - MSG Use With 18F-DCFPyL PET/CT Imaging	N/A
Recruiting	`NCT06236789` - Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer
Completed	`NCT02977143` - Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery	N/A
Completed	`NCT02966535` - The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial	N/A
Completed	`NCT00252460` - CT/MRI Co-registration Prostate Cancer	Phase 1
Completed	`NCT04398173` - Detection Rate of Prostate Cancer in Men Undergoing MRI